Major inducing factors of hypertensive complications and the interventions required to reduce their prevalence: An epidemiological study of hypertension in a rural population in China

BMC Public Health

Volumn 11, Issue , 2011, Pages

  Zhang, Min ^a   Meng, Yong ^a   Yang, Yongli ^a   Liu, Yancai ^b   Dong, Caiqin ^b   Xiao, Jianming ^a   Zhao, Ling ^a   Li, Fang ^a  

^a KUNMING MEDICAL UNIVERSITY   (China)

^b Department of Surgery   (China)

Author keywords

Chinese rural areas; complications; hypertension; the New Rural Cooperative Medical Scheme

Indexed keywords

AGED; ARTICLE; ATTITUDE TO HEALTH; CHINA; EPIDEMIOLOGY; FEMALE; HEALTH SURVEY; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; RURAL POPULATION; STATISTICAL MODEL;

AGED; CHINA; EPIDEMIOLOGIC STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SURVEYS; HUMANS; HYPERTENSION; LOGISTIC MODELS; MALE; MIDDLE AGED; RURAL POPULATION;

EID: 79955770192     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-11-301     Document Type: Article

References (34)

1. Mortality by cause for eight regions of the world: Global Burden of Disease Study. CJ Murray AD Lopez, Lancet 1997 349 9061 1269 1276 10.1016/S0140-6736(96)07493-4 9142060 (Pubitemid 27192468)
2. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997 157 21 2413 2446 9385294
3. Prevalence, awareness, treatment, and control of hypertension in china. D Gu K Reynolds X Wu J Chen X Duan P Muntner G Huang RF Reynolds S Su PK Whelton,, et al. Hypertension 2002 40 6 920 927 10.1161/01.HYP.0000040263.94619. D5 12468580 (Pubitemid 35434917)
4. Prevalence of hypertension and its trends in Chinese populations. X Wu X Duan D Gu J Hao S Tao D Fan, Int J Cardiol 1995 52 1 39 44 10.1016/0167-5273(95) 02443-Z 8707434
5. Trends in prevalence, awareness, treatment and control of hypertension in the middle-aged population of China, 1992-1998. Z Wang Y Wu L Zhao Y Li J Yang B Zhou, Hypertens Res 2004 27 10 703 709 10.1291/hypres.27.703 15785004 (Pubitemid 40045508)
6. Communiqué on National Expenditures on Science and Technology in 2005. http://www.stats.gov.cn/was40/gjtjj-en-detail.jsp?channelid= 4920&record=25
7. Reforming China's Rural Health System. http://siteresources.worldbank. org/CHINAEXTN/Resources/318949-1248160372290/rural-health-full-report-en.pdf
8. Pilot program of China's new cooprerative medical scheme system design and progress. http://www.unescap.org/ESID/hds/pubs/advo/NCMS-report.pdf
9. Medical financial assistance in rural china: policy design and implementation. Y Xu X Zhang X Zhu, Studies in HSO8P 2008 23 295 317
10. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003 21 6 1011 1053 12777938
11. Application of generalized estimating equations in analysis of multiple response. W Zhang X Tian, Chinese J Health Stat 2004 21 3 139 141
12. Worldwide prevalence of hypertension: a systematic review. PM Kearney M Whelton K Reynolds PK Whelton J He, J Hypertens 2004 22 1 11 19 10.1097/00004872-200401000-00003 15106785 (Pubitemid 38293521)
13. The prevalence of prehypertension and hypertension among US adults according to the new joint national committee guidelines: new challenges of the old problem. Y Wang QJ Wang, Arch Intern Med 2004 164 19 2126 2134 10.1001/archinte.164.19.2126 15505126 (Pubitemid 39410802)
14. From poor areas to poor people: China's evolving poverty reduction agenda. An assessment of poverty and inequality in China. http://siteresources. worldbank.org/CHINAEXTN/Resources/318949-1239096143906/China-PA-Report-March- 2009-eng.pdf
15. The influence of the rural health security schemes on health utilization and household impoverishment in rural China: data from a household survey of western and central China. W Shi V Chongsuvivatwong A Geater J Zhang H Zhang D Brombal, Int J Equity Health 2010 9 7 10.1186/1475-9276-9-7 20178565
16. The impact of different benefit packages of Medical Financial Assistance Scheme on health service utilization of poor population in rural China. Y Hao Q Wu Z Zhang L Gao N Ning M Jiao D Zakus, BMC Health Serv Res 2010 10 170 10.1186/1472-6963-10-170 20565720
17. Trends in hypertension prevalence and management in Southwestern France, 1985-1996. P Marques-Vidal JB Ruidavets JP Cambou J Ferrieres, J Clin Epidemiol 2000 53 12 1230 1235 10.1016/S0895-4356(00)00245-6 11146269 (Pubitemid 32010685)
18. Factors associated with hypertension awareness, treatment, and control in a representative sample of the chinese population. P Muntner D Gu X Wu X Duan G Wenqi PK Whelton J He, Hypertension 2004 43 3 578 585 10.1161/01.HYP. 0000116302.08484.14 14744929 (Pubitemid 38282431)
19. Prevalence, awareness, treatment, and control of hypertension in a Spanish population. A Puras C Sanchis LM Artigao JA Divison, Eur J Epidemiol 1998 14 1 31 36 10.1023/A:1007483916158 9517870 (Pubitemid 28073858)
20. The prevalence of prehypertension and hypertension among rural adults in Liaoning province of China. Z Sun L Zheng Y Wei J Li X Zhang S Liu C Xu F Zhao G Dong D Hu,, et al. Clin Cardiol 2007 30 4 183 187 10.1002/clc.20073 17443660 (Pubitemid 46642056)
21. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. AI Adler IM Stratton HA Neil JS Yudkin DR Matthews CA Cull AD Wright RC Turner RR Holman, BMJ 2000 321 7258 412 419 10.1136/bmj.321.7258. 412 10938049 (Pubitemid 30609443)
22. Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. R Collins S MacMahon, Br Med Bull 1994 50 2 272 298 8205459 (Pubitemid 24165020)
23. Blood pressure and renal function: therapeutic implications. LM Ruilope C Campo F Rodriguez-Artalejo V Lahera R Garcia-Robles JL Rodicio, J Hypertens 1996 14 11 1259 1263 10.1097/00004872-199611000-00001 8934351 (Pubitemid 26377207)
24. Lack of control of high blood pressure and treatment recommendations in Canada. N Khan A Chockalingam NR Campbell, Can J Cardiol 2002 18 6 657 661 12107423
25. The problem of uncontrolled hypertension. LH Lindholm, J Hum Hypertens 2002 16 Suppl 3 3 8 12140722
26. Hypertension prevalence, awareness, control and association with metabolic abnormalities in the San Marino population: the SMOOTH study. G Mancia G Parati C Borghi G Ghironzi E Andriani L Marinelli M Valentini F Tessari E Ambrosioni, J Hypertens 2006 24 5 837 843 10.1097/01.hjh.0000222752.67572.61 16612244 (Pubitemid 43670453)
27. How well are we managing and monitoring high blood pressure? VN Pavlik DJ Hyman, Curr Opin Nephrol Hypertens 2003 12 3 299 304 10.1097/00041552- 200305000-00012 12698069 (Pubitemid 36578066)
28. [Prevalence, treatment and control of hypertension in family practice patients in France during 1994]. L Poggi B Chamontin T Lang J Menard H Chevalier H Gallois O Cremier, Arch Mal Coeur Vaiss 1996 89 8 1075 1080 8949382 (Pubitemid 26275579)
29. Improvement in hypertension management in England: results from the Health Survey for England 2003. P Primatesta NR Poulter, J Hypertens 2006 24 6 1187 1192 10.1097/01.hjh.0000226210.95936.bc 16685220 (Pubitemid 43772327)
30. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. AV Chobanian GL Bakris HR Black WC Cushman LA Green JL Izzo Jr DW Jones BJ Materson S Oparil JT Wright Jr,, et al. JAMA 2003 289 19 2560 2572 10.1001/jama.289.19.2560 12748199 (Pubitemid 37430158)
31. Comparison of the blood pressure-lowering effects and tolerability of Losartan- and Amlodipine-based regimens in patients with isolated systolic hypertension. M Volpe Z Junren T Maxwell A Rodriguez R Gamboa P Gomez-Fernandez G Ortega-Gonzalez N Matadamas F Rodriguez,, et al. Clin Ther 2003 25 5 1469 1489 10.1016/S0149-2918(03)80133-9 12867222 (Pubitemid 36677288)
32. Efficacy of the combination of amlodipine and valsartan in patients with hypertension uncontrolled with previous monotherapy: the Exforge in Failure after Single Therapy (EX-FAST) study. Y Allemann B Fraile M Lambert M Barbier P Ferber JL Izzo Jr, J Clin Hypertens (Greenwich) 2008 10 3 185 194 10.1111/j.1751-7176.2008.07516.x
33. The efficacy and safety of low- and high-dose fixed combinations of irbesartan/hydrochlorothiazide in patients with uncontrolled systolic blood pressure on monotherapy: the INCLUSIVE trial. JM Neutel E Saunders GL Bakris WC Cushman KC Ferdinand EO Ofili JR Sowers MA Weber, J Clin Hypertens (Greenwich) 2005 7 10 578 586 10.1111/j.1524-6175.2004.04720.x
34. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. A Patel S MacMahon J Chalmers B Neal M Woodward L Billot S Harrap N Poulter M Marre M Cooper,, et al. Lancet 2007 370 9590 829 840 10.1016/S0140-6736(07)61303-8 17765963 (Pubitemid 47362321)